Fossa plans Q4 release for stone removal device
This article was originally published in Clinica
Executive Summary
Fossa Medical, which has developed the Stone Sweeper device for the quick and easy removal of kidney stones, has raised an undisclosed amount in a private financing round. The company will use the funds to get FDA approval - the Stone Sweeper is currently under review - and commercialise its product. Fossa expects the product to be available in the fourth quarter of 2002.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.